Anthea is a Paediatric Haematologist with a special interest in Sickle Cell disease and Haemoglobinopathies. She is the Director of the Clinical Haematology Department, Clinical Lead for the RCH Apheresis service, Clinical Lead for the sickle cell program at RCH and honorary fellow in the haematology research group at the Murdoch Children’s Research Institute. She completed her specialist training in Melbourne, and a clinical fellowship in Sickle Cell disease at Duke University Medical Centre, North Carolina USA. Anthea has completed the ASCP qualification in Apheresis (QIA) and is the chair of the RCH Apheresis Committee. She is the co chair of the Australian Sickle cell Working Group and a member of the International affairs committee for the American Society of Apheresis. Anthea’s clinical and research interests include comprehensive care of children and adults with sickle cell disease/haemoglobinopathies, and advancing clinical apheresis care for children.

Dr. Linda Watson has been an oncology nurse in Calgary, Alberta, Canada for over 30 years. She has held a variety of nursing and inter-professional leadership roles within the Cancer Care Alberta (CCA) provincial program and is currently the Scientific Director within Alberta’s provincial cancer care program. Dr. Watson holds an adjunct professor position with the Faculty of Nursing at the University of Calgary, but her passion for improving the patient experience has kept her committed to her full-time position as an embedded researcher within the Alberta cancer system. Committed to enhancing the person centredness of the cancer system she has worked to design, implement and study new processes, systems, and programs to enhance clinical capacity to deliver tailored, individualized care to cancer patients. These include using Patient Reported Outcomes (PROs) to improve patient experience and outcomes, the implementation and evaluation of a provincial cancer patient navigation program to improve access for marginalized populations, and a provincial transition post-treatment program that aims to improve the transition between the cancer program and primary care, while also striving to improve survivors’ outcomes.

Prof Sant-Rayn is Division head at the Walter and Eliza Hall Institute of Medical Research where his basic and public health research focuses on iron metabolism, red blood cells, and also public health control of anaemia and undernutrition. He is also a consultant haematologist at The Royal Melbourne Hospital, where he diagnoses and treats a range of non-malignant blood disorders. His broader interest encompass in the full breadth of global health, spanning from molecular aspects of inflammation/ iron interactions, through to the broader determinants of health including food security, wealth, dietary practices and culture, and ultimately, the fundamental determinants of health.

Pantep Angchaisuksiri, M.D., is Professor of Medicine and Chief of the Hemostasis and Thrombosis Unit in the Division of Hematology, Department of Medicine, at Ramathibodi Hospital, Mahidol University in Bangkok, Thailand. He also holds posts of Adjunct Associate Professor of Medicine at the University of North Carolina at Chapel Hill, School of Medicine, North Carolina, and is the Director of the Bangkok International Society on Thrombosis and Haemostasis (ISTH) Regional Training Center and Co-Director of the Bangkok International Hemophilia Training Centre of the World Federation of Hemophilia. Professor Angchaisuksiri is a medical graduate of Chulalongkorn University in Bangkok, Thailand and was trained in Internal Medicine at Prince of Songkla University and Hematology at Mahidol University. He was also a clinical and postdoctoral fellow in Hematology/Oncology at the Medical College of Virginia in Richmond, Virginia and the University of North Carolina at Chapel Hill, School of Medicine, North Carolina, USA. An active clinician, Professor Angchaisuksiri works with patients with thrombosis, hemophilia and other bleeding disorders, and has authored and co-authored papers relating to hemostasis and thrombosis in several leading international scientific journals. He is the President-elect of the ISTH, a council member of the Asian-Pacific Society on Thrombosis and Hemostasis (APSTH), and an Associate Editor of the Journal Research and Practice in Thrombosis and Haemostasis (RPTH).